Literature DB >> 25599623

Diabetes. Excess mortality in well-controlled T1DM without renal disease.

Janaka Karalliedde1, Giancarlo Viberti1.   

Abstract

The authors of a new study report that independent of renal disease, any level of glycaemia is associated with increased mortality risk in patients with type 1 diabetes mellitus. However, this view may be overly simplistic—a multifactorial approach is required to reduce excess mortality in this population.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25599623     DOI： 10.1038/nrneph.2014.249

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Authors:  Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel
Journal:  Circulation       Date:  2014-08-11       Impact factor: 29.690

2.  Glycemic control and excess mortality in type 1 diabetes.

Authors:  Marcus Lind; Ann-Marie Svensson; Mikhail Kosiborod; Soffia Gudbjörnsdottir; Aldina Pivodic; Hans Wedel; Sofia Dahlqvist; Mark Clements; Annika Rosengren
Journal:  N Engl J Med       Date:  2014-11-20       Impact factor: 91.245

3.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

Authors:  K Borch-Johnsen; S Kreiner
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-27

4.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T J Orchard; A M Secrest; R G Miller; T Costacou
Journal:  Diabetologia       Date:  2010-07-28       Impact factor: 10.122

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Generation of functional human pancreatic β cells in vitro.

Authors:  Felicia W Pagliuca; Jeffrey R Millman; Mads Gürtler; Michael Segel; Alana Van Dervort; Jennifer Hyoje Ryu; Quinn P Peterson; Dale Greiner; Douglas A Melton
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

7.  The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.

Authors:  Rose A Gubitosi-Klug
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

8.  Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Authors:  Ian H de Boer
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

9.  The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.

Authors:  Per-Henrik Groop; Merlin C Thomas; John L Moran; Johan Wadèn; Lena M Thorn; Ville-Petteri Mäkinen; Milla Rosengård-Bärlund; Markku Saraheimo; Kustaa Hietala; Outi Heikkilä; Carol Forsblom
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Type 1 diabetes through the life span: a position statement of the American Diabetes Association.

Authors:  Jane L Chiang; M Sue Kirkman; Lori M B Laffel; Anne L Peters
Journal:  Diabetes Care       Date:  2014-07       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.